Draft Regulations laid before Parliament under section 47(3) and (6)(a) of the Medicines and Medical Devices Act 2021 and paragraphs 8F(1) and 12(1) of Schedule 7 to the European Union (Withdrawal) Act 2018, for approval by resolution of each House of Parliament.
2023 No.
The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023
Made
Coming into force
The Secretary of State makes the following Regulations in exercise of the powers conferred by section 8C of, and paragraphs 1(1)(ab) and 7(2)1 of Schedule 4 and paragraph 21 of Schedule 7 to, the European Union (Withdrawal) Act 20182, and sections 15(1), 16(1)(i), 17(1)(a) and 43 of the Medicines and Medical Devices Act 20213, after having considered the matters in section 15(2) to (4) of the Medicines and Medical Devices Act 2021.
The Secretary of State has carried out a public consultation in accordance with section 45(1) of the Medicines and Medical Devices Act 2021.
In accordance with section 47(3) and (6)(a) of the Medicines and Medical Devices Act 2021 and paragraphs 8F(1)4 and 12(1) of Schedule 7 to the European Union (Withdrawal) Act 2018, a draft of this instrument has been laid before and approved by a resolution of each House of Parliament.
The Treasury have consented to the making of these Regulations as required by paragraphs 3(1) and 10 of Schedule 4 to the European Union (Withdrawal) Act 2018.